A two-site, two-arm, 34-week, double-blind, parallel-group, randomized controlled trial of reduced nicotine cigarettes in smokers with mood and/or anxiety disorders: trial design and protocol

BACKGROUND: The U.S. Food and Drug Administration can set standards for cigarettes that could include reducing their nicotine content. Such a standard should improve public health without causing unintended serious consequences for sub-populations. This study evaluates the effect of progressive nico...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Public Health
Autors principals: Allen, Sophia I., Foulds, Jonathan, Pachas, Gladys N., Veldheer, Susan, Cather, Corinne, Azzouz, Nour, Hrabovsky, Shari, Hameed, Ahmad, Yingst, Jessica, Hammett, Erin, Modesto, Jennifer, Krebs, Nicolle M., Zhu, Junjia, Liao, Jason, Muscat, Joshua E., Richie, John, Evins, A. Eden
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2017
Matèries:
Study Protocol
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5248523/
https://ncbi.nlm.nih.gov/pubmed/28103841
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12889-016-3946-4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars